Experimental Evidence for the Reorganization of β-Strands within Aggregates of the Aβ(16−22) Peptide
- 13 September 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 127 (39) , 13488-13489
- https://doi.org/10.1021/ja054663y
Abstract
Amyloidogenic deposits that accumulate in brain tissue with the progression of Alzheimer's disease contain large amounts of the amyloid β-peptide. A small fragment of this peptide, comprising residues 16−22 (Aβ(16−22)), forms β-sheets in isolation, which then aggregate into amyloid fibrils. Here, using isotope edited infrared spectroscopy to probe the secondary structure of the peptide with residue level specificity, we are able to show conclusively that the β-sheets formed are antiparallel and, following an anneal cycle or prolonged incubation, are in register with the central residue (Phe19) in alignment across all strands. The alignment of strands proceeds via a rapid interchange from one sheet to another. This realignment of the peptide strands into a more favorable registry may have important implications for therapeutics since previous work has shown that well aligned β-sheets form more stable amyloid fibrils.Keywords
This publication has 13 references indexed in Scilit:
- Correlations among Morphology, β-Sheet Stability, and Molecular Structure in Prion Peptide AggregatesBiochemistry, 2005
- In Silico Assembly of Alzheimer's Aβ16-22 Peptide into β-SheetsJournal of the American Chemical Society, 2004
- Pathway Complexity of Alzheimer's β-Amyloid Aβ16-22 Peptide AssemblyStructure, 2004
- Dissecting the Assembly of Aβ16–22 Amyloid Peptides into Antiparallel β SheetsStructure, 2003
- Protein-misfolding diseases: Getting out of shapeNature, 2002
- Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMRBiochemistry, 2000
- Isotope-Edited Infrared Spectroscopy of Helical PeptidesJournal of the American Chemical Society, 1999
- Human and rodent sequence analogs of Alzheimer's amyloid βA4 share similar properties and can be solubilized in buffers of pH 7.4European Journal of Biochemistry, 1991
- Molecular determinants of amyloid deposition in Alzheimer's disease: conformational studies of synthetic .beta.-protein fragmentsBiochemistry, 1990
- Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.Proceedings of the National Academy of Sciences, 1987